Cargando…
Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin
Cancer stem cell (CSC) markers have been identified for CSC isolation and proposed as therapeutic targets in various types of cancers. CD90, one of the characterized markers in liver and gastric cancer, is shown to promote cancer formation. However, the underexpression level of CD90 in ovarian cance...
Autores principales: | Chen, Wei-Ching, Hsu, Hui-Ping, Li, Chung-Yen, Yang, Ya-Ju, Hung, Yu-Hsuan, Cho, Chien-Yu, Wang, Chih-Yang, Weng, Tzu-Yang, Lai, Ming-Derg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063452/ https://www.ncbi.nlm.nih.gov/pubmed/27633757 http://dx.doi.org/10.3892/ijo.2016.3691 |
Ejemplares similares
-
Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer
por: Chen, Wei-Ching, et al.
Publicado: (2015) -
Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer
por: Chen, Wei-Ching, et al.
Publicado: (2016) -
Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases
por: Weng, Tzu-Yang, et al.
Publicado: (2016) -
Skin Delivery of Clec4a Small Hairpin RNA Elicited an Effective Antitumor Response by Enhancing CD8(+) Immunity In Vivo
por: Weng, Tzu-Yang, et al.
Publicado: (2017) -
Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells
por: Hung, Yu-Hsuan, et al.
Publicado: (2017)